SVM ran media outreach around Baylor’s presence at the ACMG Annual Meeting, promoting its technology updates, poster presentations, and an interview with Dr. Eng. The result was a GenomeWeb feature by Huanjia Zhang, “Playing the Long Game: At ACMG, Firms Tout Long-Read Offerings for Rare Disease Testing.”

The article compares Baylor with key competitors and highlights its approach: adding long-read sequencing and optical genome mapping (OGM) as reflex enhancements to short-read whole genome sequencing, at no extra cost to customers and with no change in turnaround time. The coverage reinforces Baylor’s leadership in rare disease diagnostics.